Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared on LinkedIn:
“Celebrating 20 years of the Translational Breast Cancer Research Consortium (TBCRC)!
For two decades, the TBCRC has brought together an incredible community of investigators advancing breast cancer research and care through innovative clinical trials, addressing important questions often left unanswered by registrational studies.
With the support of Susan G. Komen and The Breast Cancer Research Foundation, the consortium has achieved impressive milestones:
- 74 clinical trials approved
- Over 7,700 participants enrolled
- 72 peer-reviewed publications
- More than 140 scientific presentations
And much more to come, including 4 oral presentations at the upcoming SABCS26!
I’m excited to join Mitchell Elliott as Social Media Co-Chair, helping share the incredible research coming from this group and amplify its impact.
Follow the TBCRC and learn more about our activities: Translational Breast Cancer Research Consortium (TBCRC).”
Other articles about TBCRC on OncoDaily.